Luigi Coppola

Luigi Coppola is a senior researcher at Azienda Ospedaliera di Rilievo Nazionale Santobono-Pausilipon since October 2024 and has served as a biotechnologist at the University of Naples Federico II since January 2013, focusing on primary and immortalized cell cultures of breast cancer and the study of innovative molecular target drugs. Previously, Luigi worked as a researcher at Gruppo SYNLAB Italia from January 2016 to October 2024 and was a PhD student at Università degli Studi di Napoli Federico II from April 2014 to May 2017. Luigi holds a Master's degree in Medical Biotechnology from Università degli Studi di Napoli Federico II and a professional qualification as a Biologist from Università degli Studi del Sannio-Benevento. Luigi is currently pursuing a specialization in Clinical Pathology and Clinical Biochemistry at Università degli Studi di Napoli Federico II, expected to complete in March 2026.